(1545166) METTL3 contributes to aggressive CLL via post-transcriptional regulation of splicing factor

Primary Author(s)

• YW

  Yiming Wu, PhD

  Department of Systems Biology, Beckman Research Institute, City of Hope National Comprehensive Cancer Center
  Monrovia, CA, United States

Co-Author(s)

• MJ

  Meiling Jin, PhD

  Department of Systems Biology, Beckman Research Institute, City of Hope National Comprehensive Cancer Center
  Monrovia, CA, United States
• MF

  Mike Fernandez, BS

  Department of Systems Biology, Beckman Research Institute of the City of Hope
  Monrovia, CA, United States
• SF

  Stacey M. Fernandes, BS

  Dana-Farber Cancer Institute
  Boston, MA, United States
• 

  Alexey V. Danilov, MD, PhD

  Professor
  Department of Hematology and Transplantation;
  City of Hope National Medical Center
  Duarte, CA, United States
• 

  Jennifer R. Brown, MD, PhD

  Director, CLL Center & Institute Physician, DFCI; Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology, HMS
  Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI); Department of Medicine, Harvard Medical School (HMS)
  Boston, MA, United States
• SR

  Steven Rosen, MD

  Provost & Chief Scientific Officer
  Department of Hematology& Hematopoietic Cell Transplantation, Toni Stephenson Lymphoma Center, Beckman Research Institute, City of Hope Comprehensive Cancer Center
  Duarte, CA, United States
• 

  Tanya Siddiqi, MD

  Associate Professor
  City of Hope National Medical Center
  Duarte, CA, United States

Co-Author; Presenting Author(s)

• 

  Lili Wang, MD, PhD

  Associate Professor, Department of Systems Biology
  Beckman Research Institute, City of Hope National Comprehensive Cancer Center, Monrovia; Toni Stephenson Lymphoma Center, Beckman Research Institute, City of Hope Comprehensive Cancer Center
  Duarte, CA, United States

  Slides